72,234 articles
Ketanserin
Ketanserin is a selective antagonist of the serotonin 5-HT2A receptor, developed by Janssen Pharmaceutica in 1980, studied clinically as an antihypertensive and antiplatelet agent and widely used in laboratory research.
Ketazolam
Ketazolam (U-28,774; brands Anxon, Marcen, Sedotime, Solatran, Unakalm) is an Upjohn benzodiazepine anxiolytic that converts to diazepam in blood, was trialed as once-daily bedtime anxiety treatment, is UN Schedule IV, and has no FDA-approved product.
Ketchup as a vegetable
Ketchup as a vegetable: 1981 USDA proposal under Reagan to credit ketchup and pickle relish toward school lunch vegetable requirements after budget cuts; ridiculed, cancelled September 25, 1981, never enacted.
Keteleeria
Keteleeria (油杉属) is a relict conifer genus of Pinaceae, sister to Abies in the abietoid clade, native mainly to China. It has axial resin canals, disputed species limits, a Cretaceous fossil record, and endangered, climate-threatened species.
Keteleeria fortunei (油杉)
Keteleeria fortunei (油杉, Fortune's keteleeria) is a Near Threatened Pinaceae tree to 30 m from southern China and northern Vietnam, with erect cylindrical cones, timber and afforestation uses, and varieties fortunei, cyclolepis, and oblonga.
Ketoacidosis
Ketoacidosis, including diabetic ketoacidosis (DKA), alcoholic, starvation, and euglycemic forms: ketone accumulation from insulin deficiency makes blood acidic; diagnosed by ketones, pH, bicarbonate; treated with fluids, electrolytes, insulin.
Ketoconazole
Ketoconazole (Nizoral) is a Janssen imidazole antifungal, the first oral broad-spectrum drug for systemic mycoses (announced 1977, FDA-approved 1981); oral use was suspended in the EU in 2013 over hepatotoxicity, while topical forms and Cushing's syndrome use remain.
Ketogenesis
Synthesis of ketone bodies (ketogenesis): hepatic mitochondrial pathway converting acetyl-CoA into acetoacetate, beta-hydroxybutyrate, and acetone via ACAT1, HMGCS2 (rate-limiting), HMGCL, and BDH1, active during fasting and suppressed by insulin.
Ketogenic diet
Ketogenic diet: very low-carbohydrate, high-fat diet inducing nutritional ketosis (blood BHB >0.5 mmol/L). Developed by Wilder in 1921 for epilepsy; also used for weight loss, with lipid and ketoacidosis cautions.
Ketohexokinase
Ketohexokinase (KHK, fructokinase), EC 2.7.1.3, is the enzyme that phosphorylates fructose to fructose 1-phosphate, the first step of fructolysis. Two splice isoforms, hepatic KHK-C (Km 0.8 mM) and ubiquitous KHK-A (Km 8 mM); deficiency causes benign essential fructosuria; inhibitors PF-06835919 and LY3522348 are in clinical trials.
Ketolysis
Ketolysis is the mitochondrial breakdown of ketone bodies (β-hydroxybutyrate, acetoacetate) into acetyl-CoA via BDH1, SCOT/OXCT1, and ACAT in brain, heart, skeletal muscle, and kidney; the liver performs ketogenesis but not ketolysis.
Ketone bodies
Ketone bodies (acetoacetate, acetone, beta-hydroxybutyrate) are liver-derived alternative fuels made during fasting, low-carbohydrate diets, and exercise; normal levels under 0.1 mmol/L, DKA threshold 3.0 mmol/L.
Ketone body metabolism
Ketone body metabolism: hepatic mitochondrial synthesis of acetoacetate, beta-hydroxybutyrate, and acetone from acetyl-CoA (ketogenesis) and extrahepatic oxidation via SCOT (ketolysis), active in fasting and diabetic ketoacidosis.
Ketone body transport
Ketone body transport is the movement of ketone bodies from the liver through the blood into tissues like brain, muscle, and heart via monocarboxylate transporters.
Ketonuria
Ketonuria, also called urine ketones or ketone bodies in urine, is the excretion of acetoacetate, beta-hydroxybutyrate, and acetone in urine during fasting, ketogenic diet, pregnancy, or diabetic ketoacidosis; dipstick tests detect acetoacetate but not beta-hydroxybutyrate.
Ketoprofen
Ketoprofen (C16H14O3) is a propionic acid derivative NSAID inhibiting COX-1/COX-2, synthesized by Rhône-Poulenc in 1967 and marketed since 1973; US approval 1986 (Orudis), OTC 12.5 mg tablets 1995, with topical photoallergy risk and veterinary use (KetoMed).
Ketorolac
Ketorolac (Toradol) is a potent non-selective COX-inhibiting NSAID given orally, IV, IM, intranasally, or as eye drops for short-term (up to 5 days) moderate-to-severe acute pain, with opioid-sparing effects but the highest GI bleeding risk among NSAIDs.
Ketosis
Ketosis, medically called hyperketonemia, is a metabolic state in which blood ketone bodies rise because the body burns fatty acids, occurring in fasting, exercise, and ketogenic diets.
Ketosteroid isomerase
Ketosteroid isomerase (KSI, EC 5.3.3.1, steroid Δ-isomerase) is a bacterial homodimeric enzyme converting 3-oxo-Δ5-steroids to Δ4 isomers via a dienolate intermediate, cofactor-free, near diffusion-limited, a model for enzyme electrostatic catalysis.
Ketotic hypoglycemia
Ketotic hypoglycemia (KH), also called idiopathic ketotic hypoglycemia or accelerated starvation, is hypoglycemia with elevated ketones in children after fasting or illness; the most common childhood hypoglycemia cause, typically ages 10 months to 6 years, remitting by school age.
Ketotifen
Ketotifen (Zaditen, Zaditor, Totifen) is a sedating first-generation H1-antihistamine and mast cell stabilizer developed by Sandoz in 1970, used orally for asthma prophylaxis and allergy and as 0.025% eye drops for allergic conjunctivitis; not first-line asthma therapy per guidelines.
KETProject trial
KETProject (KETAMIM, NCT04234776) was a University of São Paulo Phase 4 quadruple-blind trial of intramuscular ketamine 0.75 mg/kg versus escitalopram plus aripiprazole in treatment-resistant depression, reporting comparable efficacy and no serious events.
Kettlebell
Kettlebell (girya, гиря): cannonball-shaped cast iron or steel weight with a top handle used for strength, conditioning, and the sport of kettlebell lifting; girya first recorded in a 1704 Russian dictionary, sport founded 1948.
Keutel syndrome
Keutel syndrome (KTLS, OMIM 245150) is an extremely rare autosomal recessive disorder caused by MGP gene mutations, featuring cartilage calcification, brachytelephalangism, peripheral pulmonary artery stenoses, hearing loss, and facial dysmorphism.
Kevan C. Herold
Kevan C. Herold is an American immunologist and endocrinologist at Yale School of Medicine known for leading the clinical development of teplizumab, the first drug approved to delay type 1 diabetes.
Kevan Shokat
Kevan Shokat, born 1964, is an American chemical biologist at UCSF and UC Berkeley whose K-Ras pocket discovery led to sotorasib, the first drug against the undruggable cancer protein.
Keverprazan hydrochloride
Keverprazan hydrochloride (盐酸凯普拉生, H008, brand Beiwen) is a Chinese class 1 potassium-competitive acid blocker by Carephar, NMPA-approved in 2023 for duodenal ulcer, reflux esophagitis, and H. pylori eradication.
Kevin A. Janes
Kevin A. Janes is an American systems biologist and bioengineer at the University of Virginia, known for data-driven modeling of signaling networks controlling cell death.
Kevin A. Schulman
Kevin A. Schulman is an American health services researcher and health economist, a Stanford School of Medicine professor since 2018 known for a 1999 NEJM study.
Kevin Brown (physician-scientist)
Kevin E. Brown is a physician-scientist in infectious diseases known for parvovirus B19 research and measles and rubella surveillance at the United Kingdom's national virus reference laboratory.